Shukun Technology
Founded Year
2017Stage
Series D | AliveTotal Raised
$250.65MValuation
$0000Last Raised
$108.09M | 4 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-98 points in the past 30 days
About Shukun Technology
Shukun Technology provides smart medical and health technology platform services. The company offers a suite of artificial intelligence-powered diagnostic assistance products that cover common and significant diseases across various human body parts. Shukun Technology also provides comprehensive solutions for medical imaging, surgical planning, and health management, leveraging multimodality technology and original research to serve the healthcare industry. It was founded in 2017 and is based in Beijing, China.
Loading...
ESPs containing Shukun Technology
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The cardiac CT analytics platforms market is focused on improving the diagnosis and management of heart disease through the use of artificial intelligence and advanced imaging technologies. Companies in this market use tech to accurately detect and analyze features such as coronary artery stenosis, ventricular hypertrophy, and other anomalies that can be indicative of cardiac-related diseases. Tec…
Shukun Technology named as Challenger among 10 other companies, including Cleerly, HeartFlow, and Ultromics.
Shukun Technology's Products & Differentiators
digital body
digital body
Loading...
Research containing Shukun Technology
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Shukun Technology in 1 CB Insights research brief, most recently on Dec 7, 2022.
Expert Collections containing Shukun Technology
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Shukun Technology is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Artificial Intelligence
10,027 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
11,306 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
The winners of the third annual CB Insights Digital Health 150.
Latest Shukun Technology News
Apr 7, 2025
数坤科技社（Shukun）との包括的戦略パートナーシップ契約締結のお知らせ 2025年4月7日 15時00分 クレアボ・テクノロジーズ株式会社（本社：東京都千代田区、代表取締役CEO兼社長：山田 理一、以下、「クレアボ社」）は、Shukun Technology Co., Ltd.（本社：中華人民共和国、北京、CEO：Anne Ma、以下、「Shukun社」）と日本における包括的パートナーシップ契約を締結致しました。 今回の包括的パートナーシップ契約は、日本市場におけるShukun社の開発する医療画像AI製品群の継続的かつ効果的な導入に向けた体制の整備と協働の深化を図ります。 同社は心臓、脳、胸部、腹部、筋骨格系（MSK）の疾患領域において包括的な医療画像AI製品群を「Digital Body AI プラットフォーム」上で提供し、これらはCT、MRI、X線、マンモグラフィ、超音波など多様な画像診断機器に対応しています。 この提携により、両社は日本国内市場におけるShukun社AI製品導入を積極的に進めるための製品検討並びに評価を推進し、Shukun社が有する各製品の国内導入を加速していきます。両社はともに、各自の専門性を活かした連携により、AI技術を用いた革新的 な医療機器ソフトウェアプラットフォームの構築を目指します。これにより、医療現場における業務効率の向上と医療従事者の負担軽減に具体的な効果をもたらすことが期待されます。 Shukun社共同創設者兼会長Victor Mao氏は、 「Shukun社は世界をリードする医療画像AI製品群を開発し、「Digital Body AI プラットフォーム」上で提供しています。これにより、Shukun社は世界中の数千の病院に対してサービスを提供しています。さらに、このプラットフォームでは現在、大規模言語モデル（LLM）の機能とハードウェア設計・展開能力を統合し、世界中の医療現場において医療従事者の診断・治療判断を支援できるような「AIアシスタント」機能[i]の研究開発を進めています。昨年、クレアボ社との協業により日本で初めての心臓関連AI製品を発売し、大きな成功を収めました。今回、クレアボ社とより包括的な戦略的パートナーシップを締結することで、より多くの製品および「Digital Body AIプラットフォーム」を日本市場に導入できることを嬉しく思います。技術に国境はありません—Shukun社とクレアボ社は共に、質の高い医療をすべての人々にとってよりアクセスしやすいものにすることに取り組んでいます。」と述べております。 クレアボ社代表取締役CEO兼社長山田理一氏は、 「世界の医療AI分野をリードするShukun社との提携が実現し、私たちの社員一同、とても嬉しく思っています。「大切な人へ、未来の医療を、共に。」という理念のもと歩んできた私たちにとって、同じ志を持つパートナーとの提携は、まさに願ってもない機会です。この提携により、多くの最先端の医療技術を日本の医療現場にお届けできるようになります。Shukun社の革新的な技術と、私たちの日本の医療現場への理解が合わさることで、医師・医療従事者の皆さまの日々の診療をサポートし、患者の健康に貢献できると確信しています。両社の強みを活かした新しいソリューションで、医療の未来を共に創っていく旅に、どうぞご期待ください！」と述べております。 ■パートナーシップ経緯
Shukun Technology Frequently Asked Questions (FAQ)
When was Shukun Technology founded?
Shukun Technology was founded in 2017.
Where is Shukun Technology's headquarters?
Shukun Technology's headquarters is located at Room 801, Jinhui Building, Qiyang Road, Chaoyang District, Beijing.
What is Shukun Technology's latest funding round?
Shukun Technology's latest funding round is Series D.
How much did Shukun Technology raise?
Shukun Technology raised a total of $250.65M.
Who are the investors of Shukun Technology?
Investors of Shukun Technology include Marathon Venture Partners, HongShan, Primavera Capital Group, WT Focus on China Fund, Jane Street Group and 16 more.
Who are Shukun Technology's competitors?
Competitors of Shukun Technology include Deepwise and 4 more.
What products does Shukun Technology offer?
Shukun Technology's products include digital body.
Loading...
Compare Shukun Technology to Competitors
Yizhun Intelligence focuses on the development of artificial intelligence that assists medical imaging diagnosis. The company was founded in 2017 and is based in Beijing, China.
Shenzhi Technology focuses on ultrasound diagnostic intelligence and ultrasound AI applications for thyroid, breast, liver, carotid plaque, pelvic floor, orthopedics, neurology, and other diseases.
Provider of medical image analytics solutions. The company specializes in the development of artificial intelligence (AI) powered medial image analytics solutions. The products are applied in medical image automatic detection and diagnosis, surgery planning, navigation and evaluation.
RAMZED is a company specializing in medical imaging technology within the healthcare sector. It offers diagnostic systems including wireless handheld color ultrasound imaging, ultrasound contrast, and digital medical X-ray photography systems. These products are designed to provide high-quality medical imaging for various clinical applications. It is based in Yueyang, Hunan.
Ultromics operates within the medical technology industry and focuses on heart failure detection. The company offers diagnostic tools that analyze echocardiograms to identify conditions such as heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing clinicians with reports to assist in clinical decisions. Ultromics serves healthcare providers, including hospitals and clinics, by integrating its technology into existing medical imaging workflows. It was founded in 2017 and is based in Oxford, England.
Knowledge Vision aims to use artificial intelligence to help doctors in making accurate diagnosis through medical artificial intelligence and medical image processing technologies.
Loading...